Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Texas

818 recruiting clinical trials across 15 cities in Texas (TX). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
818
Total Trials
818
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Texas

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00756665

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance...

Sponsor: University of WashingtonEnrolling: 300011 locations
Prostatic Neoplasms
RECRUITINGPhase 2NCT00801489

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating...

This phase II trial studies the side effects and how well fludarabine phosphate, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin hydrochloride work in treating...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 2701 location
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1+7
RECRUITINGNCT00991094

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 50001 location
Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6
RECRUITINGNCT01018537

NARCOMS Registry: A Multiple Sclerosis Registry

This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 500001 location
Multiple Sclerosis
RECRUITINGNCT01266915

Cutaneous Lupus Registry

Approximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 10001 location
Lupus Erythematosus
RECRUITINGNCT01365169

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and...

The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider...

Sponsor: M.d. Anderson Cancer CenterEnrolling: 5901 location
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45
RECRUITINGPhase 1 / Phase 2NCT01371630

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

This phase I/II trial studies the side effects and best dose of inotuzumab ozogamicin and to see how well it works when given together with combination chemotherapy in treating...

Sponsor: M.d. Anderson Cancer CenterEnrolling: 2761 location
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6
RECRUITINGPhase 1 / Phase 2NCT01659203

Proton or Photon RT for Retroperitoneal Sarcomas

This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate...

Sponsor: Massachusetts General HospitalEnrolling: 8010 locations
Retroperitoneal Sarcoma
RECRUITINGNCT01668082

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

The study is designed to use infusion of a non-radioactive, naturally occurring isotope of glucose (13C) in patients undergoing surgical resection for a newly identified brain...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 401 location
Brain Mass
RECRUITINGNCT01694940

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Sponsor: Columbia UniversityEnrolling: 100017 locations
Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial Diseases+2
RECRUITINGNCT01808937

Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository

The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 5001 location
Scleroderma, LocalizedMorpheaFrontal Linear Scleroderma en Coup de Sabre+2
RECRUITINGNCT01860339

Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease

Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat...

Sponsor: Peggy C NopoulosEnrolling: 4006 locations
Huntington's Disease
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGPhase 1 / Phase 2NCT01906385

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced...

Sponsor: Plus TherapeuticsEnrolling: 553 locations
Glioma
RECRUITINGNCT02138669

Intacs Prescription Inserts for Keratoconus Patients

The US food and Drug Administration (FDA) originally approved INTACS prescription inserts in April 1999 for the correction of low levels of nearsightedness (-1.00 to -3.00...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 251 location
Keratoconus
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGNCT02280733

A Real-World Registry of Chronic Wounds and Ulcers

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data...

Sponsor: U.S. Wound RegistryEnrolling: 3000001 location
Diabetic FootPressure UlcerSurgical Wound Dehiscence+17
RECRUITINGPhase 1 / Phase 2NCT02332668

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma...

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: *...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 37017 locations
MelanomaLymphomaSolid Tumor+2
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 2NCT02479698

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from...

Sponsor: M.d. Anderson Cancer CenterEnrolling: 1001 location
Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5
RECRUITINGPhase 3NCT02670707

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Langerhans Cell Histiocytosis (LCH) is a type of cancer that can damage tissue or cause lesions to form in one or more places in the body. Langerhans cell histiocytosis (LCH) is a...

Sponsor: Baylor College of MedicineEnrolling: 12411 locations
Langerhans Cell Histiocytosis
RECRUITINGPhase 2NCT02727803

Personalized NK Cell Therapy in CBT

This phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in treating patients with...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1001 location
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia+23
RECRUITINGNCT02804438

Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care

The purpose of this study is to collect a large amount of data that may assist in addressing the gap in knowledge of understanding pupillometer readings using a pupillometer...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 10001 location
Critical IllnessNeuropathy
RECRUITINGNCT02855476

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for...

HDClarity will seek at least 2500 research participants at different stages of Huntington's disease (HD). The primary objective is to collect a high quality CSF sample for...

Sponsor: University College, LondonEnrolling: 250020 locations
Huntington's Disease
RECRUITINGNCT02916810

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

The purpose of the study is to test the hypothesis that functionally navigated repetitive TMS stimulations to the prefrontal cortex (PFC) modulate aberrant cortical electrical...

Sponsor: The University of Texas Health Science Center, HoustonEnrolling: 1401 location
Schizophrenia and Related Disorders
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B
RECRUITINGPhase 1NCT02962661

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by...

This randomized pilot phase I trial studies the side effects of donor bone marrow derived mesenchymal stem cells in controlling heart failure in patients with cardiomyopathy...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 721 location
CardiomyopathyHeart FailureHematopoietic and Lymphoid Cell Neoplasm+1
RECRUITINGPhase 2NCT03007030

Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

This phase II trial studies how well brentuximab vedotin works in treating patients with CD30 positive (+) malignant mesothelioma that cannot be removed by surgery. Monoclonal...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 551 location
CD30-Positive Neoplastic Cells PresentMalignant Mesothelioma
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGPhase 1NCT03025256

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

This phase I/Ib trial studies the side effects and best dose of intrathecal nivolumab, and how well it works in combination with intravenous nivolumab in treating patients with...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 751 location
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7

Showing 30 of 818 trials in Texas. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 818 clinical trials actively recruiting participants in Texas. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Texas include Ovarian Cancer, Colorectal Cancer, Breast Cancer, Advanced Solid Tumor, Multiple Myeloma. Each has multiple active trials across research centers in the state.

Major trial sites in Texas include Houston, Dallas, San Antonio, Austin, Fort Worth. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.